Literature DB >> 20694792

Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitment.

Clara Di Filippo1, Margherita Luongo, Raffaele Marfella, Franca Ferraraccio, Biagio Lettieri, Annalisa Capuano, Francesco Rossi, Michele D'Amico.   

Abstract

The purpose of this study is to investigate whether an oxygen/ozone (O(2)/O(3)) mixture protects the heart from acute myocardial infarction through local involvement of endothelial nitric oxide synthase (eNOS) and endothelial progenitor cells (EPCs). Male Sprague-Dawley rats were subject to 25-min occlusion and 2-h reperfusion of the left descending coronary artery. O(2)/O(3) mixture was insufflated i.p. 30 min prior to ischemia/reperfusion (I/R) procedure at doses of 100, 150, and 300 microg/kg. Myocardial infarct size (IS) measurement and myocardial immunohistochemistry for EPCs were done. For these latter cells, immunoreactivities for CD34, and CD117/c-kit were assessed within the infarcted tissue. Moreover, cardiac eNOS was monitored. I/R in rats treated with O(2) produced an IS as a percentage of the area at risk (IS/AR) equal to 51 +/- 5%. I/R in rats treated with the O(2)/O(3) mixture showed reduced IS (for example, IS/AR for 150 microg/kg O(2)/O(3) was 35 +/- 2.1%; P < 0.01 vs. O(2)). The O(2)/O(3) cardio-protection was paralleled by an increased number of immunopositive particles per area for CD34 and CD117/c-kit. The increase of these markers was associated with an increase of cardiac eNOS expression as assayed by immunohistochemistry. Interestingly, N5-(1-Iminoethyl)-L-ornithine dihydrochloride (L-NIO), a selective eNOS activity inhibitor (30 mg/kg s.c.), prior to O(2)/O(3) and I/R almost abolished the cardio-protection exerted by the O(2)/O(3) mixture. L-NIO also abolished the increase in immunostaining for CD-34 and CD117/c-kit as compared with the rats receiving O(2)/O(3) and I/R only. O(2)/O(3) mixture protects the heart from acute myocardial infarction through local increase of eNOS expression/activity and consequent EPCs recruitment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694792     DOI: 10.1007/s00210-010-0545-2

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation.

Authors:  Tao-Sheng Li; Kimikazu Hamano; Masahiko Nishida; Masanori Hayashi; Hiroshi Ito; Akihito Mikamo; Masunori Matsuzaki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-09       Impact factor: 4.733

2.  Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.

Authors:  A A Kocher; M D Schuster; M J Szabolcs; S Takuma; D Burkhoff; J Wang; S Homma; N M Edwards; S Itescu
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

3.  Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model.

Authors:  Alexander Schuh; Elisa A Liehn; Alexander Sasse; Mihail Hristov; Radoslaw Sobota; Malte Kelm; Marc W Merx; Christian Weber
Journal:  Basic Res Cardiol       Date:  2007-11-12       Impact factor: 17.165

4.  Endothelial progenitor cells in cell-based therapy for cardiovascular disease.

Authors:  N Rodriguez-Losada; J M Garcia-Pinilla; M F Jimenez-Navarro; F J Gonzalez
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2008-10-26       Impact factor: 1.770

5.  Low angiogenic potency induced by the implantation of ex vivo expanded CD117(+) stem cells.

Authors:  Tao-Sheng Li; Masanori Hayashi; Ze-Lin Liu; Hiroshi Ito; Akihito Mikamo; Akira Furutani; Masunori Matsuzaki; Kimikazu Hamano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12-04       Impact factor: 4.733

6.  Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct.

Authors:  C Di Filippo; R Marfella; P Capodanno; F Ferraraccio; L Coppola; M Luongo; L Mascolo; C Luongo; A Capuano; F Rossi; M D'Amico
Journal:  Inflamm Res       Date:  2008-10       Impact factor: 4.575

Review 7.  Endothelial dysfunction in heart failure.

Authors:  Johann Bauersachs; Julian D Widder
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

8.  Role of endothelial nitric oxide synthase in aggravation of indomethacin-induced gastric damage in adjuvant arthritic rats.

Authors:  S Kato; F Ohkawa; Y Ito; K Amagase; K Takeuchi
Journal:  J Physiol Pharmacol       Date:  2009-12       Impact factor: 3.011

9.  Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats.

Authors:  Mitsuyasu Matsumura; Noboru Fukuda; Naohiko Kobayashi; Hisaki Umezawa; Ayako Takasaka; Taro Matsumoto; En-Hui Yao; Takahiro Ueno; Nanao Negishi
Journal:  J Atheroscler Thromb       Date:  2009-08-11       Impact factor: 4.928

Review 10.  The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia.

Authors:  Haruki Sekiguchi; Masaaki Ii; Douglas W Losordo
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

View more
  9 in total

Review 1.  c-kit(+) cells: the tell-tale heart of cardiac regeneration?

Authors:  Patrizia Nigro; Gianluca Lorenzo Perrucci; Aoife Gowran; Marco Zanobini; Maurizio C Capogrossi; Giulio Pompilio
Journal:  Cell Mol Life Sci       Date:  2015-01-10       Impact factor: 9.261

2.  The effect of ozone on blood pressure in DOCA-salt-induced hypertensive rats.

Authors:  Raziye Akcılar; Sezer Akçer; Hasan Şimşek; Aydın Akcılar; Zeynep Bayat; Osman Genç
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 3.  Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.

Authors:  Salvatore Chirumbolo; Luigi Valdenassi; Vincenzo Simonetti; Dario Bertossi; Giovanni Ricevuti; Marianno Franzini; Sergio Pandolfi
Journal:  Int Immunopharmacol       Date:  2021-05-11       Impact factor: 5.714

4.  Ozone acting on human blood yields a hormetic dose-response relationship.

Authors:  Velio A Bocci; Iacopo Zanardi; Valter Travagli
Journal:  J Transl Med       Date:  2011-05-17       Impact factor: 5.531

5.  Intraperitoneal oxygen/ozone treatment decreases the formation of experimental postsurgical peritoneal adhesions and the levels/activity of the local ubiquitin-proteasome system.

Authors:  Clara Di Filippo; Annalisa Capuano; Barbara Rinaldi; Margherita Luongo; Biagio Lettieri; Francesco Rossi; Michele D'Amico
Journal:  Mediators Inflamm       Date:  2011-09-29       Impact factor: 4.711

Review 6.  The Biochemical and Pharmacological Properties of Ozone: The Smell of Protection in Acute and Chronic Diseases.

Authors:  Rosaria Di Mauro; Giuseppina Cantarella; Renato Bernardini; Michelino Di Rosa; Ignazio Barbagallo; Alfio Distefano; Lucia Longhitano; Nunzio Vicario; Daniela Nicolosi; Giacomo Lazzarino; Daniele Tibullo; Maria Eugenia Gulino; Mariarita Spampinato; Roberto Avola; Giovanni Li Volti
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

7.  Short-term exposure to ozone does not impair vascular function or affect heart rate variability in healthy young men.

Authors:  Stefan Barath; Jeremy P Langrish; Magnus Lundbäck; Jenny A Bosson; Colin Goudie; David E Newby; Thomas Sandström; Nicholas L Mills; Anders Blomberg
Journal:  Toxicol Sci       Date:  2013-07-19       Impact factor: 4.849

8.  Trichosanthes pericarpium Aqueous Extract Enhances the Mobilization of Endothelial Progenitor Cells and Up-regulates the Expression of VEGF, eNOS, NO, and MMP-9 in Acute Myocardial Ischemic Rats.

Authors:  Nini Fu; Hang Li; Jingchang Sun; Liying Xun; Dongmei Gao; Qitao Zhao
Journal:  Front Physiol       Date:  2018-01-17       Impact factor: 4.566

Review 9.  Cardiac Progenitor Cells and the Interplay with Their Microenvironment.

Authors:  Arianna Mauretti; Sergio Spaans; Noortje A M Bax; Cecilia Sahlgren; Carlijn V C Bouten
Journal:  Stem Cells Int       Date:  2017-09-17       Impact factor: 5.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.